NASDAQ:LOGC LogicBio Therapeutics Q1 2024 Earnings Report Earnings History LogicBio Therapeutics EPS ResultsActual EPS-$2.43Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ALogicBio Therapeutics Revenue ResultsActual Revenue$36.00 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ALogicBio Therapeutics Announcement DetailsQuarterQ1 2024Date5/8/2024TimeN/AConference Call DateWednesday, May 8, 2024Conference Call Time5:00PM ETConference Call ResourcesConference Call AudioConference Call TranscriptPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by LogicBio Therapeutics Q1 2024 Earnings Call TranscriptProvided by QuartrMay 8, 2024 ShareLink copied to clipboard.There are 4 speakers on the call. Operator00:00:00Thank you for standing by, and welcome to the ContextLogix First Quarter 2024 Earnings Conference Call. During the program today, all participants are in a listen only mode. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Ralph Fong, Director of Investor Relations. Speaker 100:00:23Thanks, Jonathan. Good afternoon, everyone, and welcome to ContextLogic's First Quarter 2024 Update Conference Call. I'm Ralph Fung, Director of Investor Relations. And providing remarks on the call today are Chairman, Chairperson and CEO, Rishi Bajaj and our CFO, Rajesh. The remarks made today may include forward looking statements, including with respect to the recent asset sale to Q10 and related matters. Speaker 100:00:54Our actual results may differ materially from the results implied by these forward looking statements if certain risks materialize or assumptions prove incorrect. Forward looking statements are based on our current expectations and assumptions and involve risks and uncertainties that could cause actual results or events to be materially different from those anticipated. Additional information concerning factors that could cause actual results to differ materially from those in the forward looking statements are and will be contained from time to time in our SEC filings, including on Forms 10Q, 10 ks and 8 ks. Any forward looking statements that we make today are only as of today's date, and we undertake no obligation to update or revise any such statements as a result of new information, future events or otherwise. Also, please keep in mind that included in the financial statements in management's prepared remarks during the call are both GAAP and non GAAP financial numbers and metrics. Speaker 100:01:59A reconciliation of non GAAP to GAAP results is included in today's earnings release, which you can find on our Investor Relations website and which is also filed with the SEC. A replay of this call will be posted to our Investor Relations website. With that, let me now turn the call over to our CFO, Burgess, to provide a financial overview. Fred? Speaker 200:02:23Thank you, Ralph. For this quarter, our financial presentation will be a little different. Our earnings press release describes our earnings for the Q1. If you want additional details, I encourage you to review that release. However, all of the revenues and earnings disclosed in that release were generated by assets that we no longer own. Speaker 200:02:44Q10 now owns those assets. Significantly, Q10 also has assumed substantially all of the liabilities associated with those assets. So instead of discussing historical results, I thought it would be more helpful to talk about our financial picture today. After the asset sale to Q10 closed on April 19, ContextLogic had approximately $2,700,000,000 of NOL carryforwards and approximately $161,000,000 in cash, cash equivalents and marketable securities, which consist of government securities. Combined, this represents the net proceeds from the sale. Speaker 200:03:22We have no debt. We have gone from nearly 500 employees worldwide at December 31 to 12 full time and part time employees, including some temporary or contract employees. We are no longer liable for any of our old leases, including our former corporate headquarters in San Francisco. We have moved across the Bay and are now leasing a small space in Oakland with our workforce totally remote. So we are starting our next chapter on strong financial footing, which is intended to give us flexibility to pursue strategic transactions that will utilize our assets. Speaker 200:04:01For additional information on that important topic, I will now turn the call over to ContextLogic's Chairperson and CEO, Rishi Bajaj. Speaker 300:04:11Thank you, Brett. I would like to thank everyone for joining our Q1 2024 update call. First and foremost, we are pleased to have completed the previously announced sale of the Wish e commerce platform to Q10. On behalf of the entire ContentLogic team, I would like to thank our stockholders for their support of this value maximizing transaction. I would also like to thank our employees for their hard work and dedication. Speaker 300:04:34With the transaction now behind us, we are excited to start this new chapter. We have begun reviewing strategic opportunities for the use of our post closing cash. Looking ahead, our reconstituted Board along with our management team will develop a process and procedure for evaluating alternatives for the use of our post closing cash and reviewing, identifying and executing strategic opportunities for the benefit of ContentLogic and its stockholders. Furthermore, as Brett noted, our overhead is very small. Simply put, we expect ContactLogic to have low operating expenses and significant opportunities for value creation. Speaker 300:05:07I'm energized by the opportunities ahead of us. We have the right strategy in place and an outstanding new leadership team to implement it. In sum, we have turned the page to begin a new chapter in the life of the company. We're excited about our future and we look forward to updating you on our progress in a few months. Again, thank you very much for joining us today and goodbye. Operator00:05:27Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.Read morePowered by Conference Call Audio Live Call not available Earnings Conference CallLogicBio Therapeutics Q1 202400:00 / 00:00Speed:1x1.25x1.5x2x Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) LogicBio Therapeutics Earnings HeadlinesContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025March 10, 2025 | globenewswire.comElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.April 20, 2025 | Colonial Metals (Ad)LOGC stock touches 52-week high at $8.24 amid market optimismFebruary 14, 2025 | msn.comContextLogic Inc. Reports Third-Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.comLGCB Linkage Global IncSeptember 15, 2024 | seekingalpha.comSee More LogicBio Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like LogicBio Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LogicBio Therapeutics and other key companies, straight to your email. Email Address About LogicBio TherapeuticsLogicBio Therapeutics (NASDAQ:LOGC), a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.View LogicBio Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead Upcoming Earnings Tesla (4/22/2025)Intuitive Surgical (4/22/2025)Verizon Communications (4/22/2025)Canadian National Railway (4/22/2025)Novartis (4/22/2025)RTX (4/22/2025)3M (4/22/2025)Capital One Financial (4/22/2025)General Electric (4/22/2025)Danaher (4/22/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 4 speakers on the call. Operator00:00:00Thank you for standing by, and welcome to the ContextLogix First Quarter 2024 Earnings Conference Call. During the program today, all participants are in a listen only mode. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Ralph Fong, Director of Investor Relations. Speaker 100:00:23Thanks, Jonathan. Good afternoon, everyone, and welcome to ContextLogic's First Quarter 2024 Update Conference Call. I'm Ralph Fung, Director of Investor Relations. And providing remarks on the call today are Chairman, Chairperson and CEO, Rishi Bajaj and our CFO, Rajesh. The remarks made today may include forward looking statements, including with respect to the recent asset sale to Q10 and related matters. Speaker 100:00:54Our actual results may differ materially from the results implied by these forward looking statements if certain risks materialize or assumptions prove incorrect. Forward looking statements are based on our current expectations and assumptions and involve risks and uncertainties that could cause actual results or events to be materially different from those anticipated. Additional information concerning factors that could cause actual results to differ materially from those in the forward looking statements are and will be contained from time to time in our SEC filings, including on Forms 10Q, 10 ks and 8 ks. Any forward looking statements that we make today are only as of today's date, and we undertake no obligation to update or revise any such statements as a result of new information, future events or otherwise. Also, please keep in mind that included in the financial statements in management's prepared remarks during the call are both GAAP and non GAAP financial numbers and metrics. Speaker 100:01:59A reconciliation of non GAAP to GAAP results is included in today's earnings release, which you can find on our Investor Relations website and which is also filed with the SEC. A replay of this call will be posted to our Investor Relations website. With that, let me now turn the call over to our CFO, Burgess, to provide a financial overview. Fred? Speaker 200:02:23Thank you, Ralph. For this quarter, our financial presentation will be a little different. Our earnings press release describes our earnings for the Q1. If you want additional details, I encourage you to review that release. However, all of the revenues and earnings disclosed in that release were generated by assets that we no longer own. Speaker 200:02:44Q10 now owns those assets. Significantly, Q10 also has assumed substantially all of the liabilities associated with those assets. So instead of discussing historical results, I thought it would be more helpful to talk about our financial picture today. After the asset sale to Q10 closed on April 19, ContextLogic had approximately $2,700,000,000 of NOL carryforwards and approximately $161,000,000 in cash, cash equivalents and marketable securities, which consist of government securities. Combined, this represents the net proceeds from the sale. Speaker 200:03:22We have no debt. We have gone from nearly 500 employees worldwide at December 31 to 12 full time and part time employees, including some temporary or contract employees. We are no longer liable for any of our old leases, including our former corporate headquarters in San Francisco. We have moved across the Bay and are now leasing a small space in Oakland with our workforce totally remote. So we are starting our next chapter on strong financial footing, which is intended to give us flexibility to pursue strategic transactions that will utilize our assets. Speaker 200:04:01For additional information on that important topic, I will now turn the call over to ContextLogic's Chairperson and CEO, Rishi Bajaj. Speaker 300:04:11Thank you, Brett. I would like to thank everyone for joining our Q1 2024 update call. First and foremost, we are pleased to have completed the previously announced sale of the Wish e commerce platform to Q10. On behalf of the entire ContentLogic team, I would like to thank our stockholders for their support of this value maximizing transaction. I would also like to thank our employees for their hard work and dedication. Speaker 300:04:34With the transaction now behind us, we are excited to start this new chapter. We have begun reviewing strategic opportunities for the use of our post closing cash. Looking ahead, our reconstituted Board along with our management team will develop a process and procedure for evaluating alternatives for the use of our post closing cash and reviewing, identifying and executing strategic opportunities for the benefit of ContentLogic and its stockholders. Furthermore, as Brett noted, our overhead is very small. Simply put, we expect ContactLogic to have low operating expenses and significant opportunities for value creation. Speaker 300:05:07I'm energized by the opportunities ahead of us. We have the right strategy in place and an outstanding new leadership team to implement it. In sum, we have turned the page to begin a new chapter in the life of the company. We're excited about our future and we look forward to updating you on our progress in a few months. Again, thank you very much for joining us today and goodbye. Operator00:05:27Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.Read morePowered by